title: c-Met expression in a gastric cancer cell line producing alpha-fetoprotein.
abstract: OBJECTIVE
  We previously reported a higher frequency of c-Met protein expression and high proliferative status in gastric cancers producing alpha-fetoprotein (AFP) than in those not producing AFP.
  
  
  METHODS
  To investigate this further, we established an AFP-producing gastric cancer cell line, designated as AME-1, from the primary tumor of a patient with AFP-producing gastric cancer.
  
  
  RESULTS
  alpha-Fetoprotein production in the AME-1 cell line was confirmed at the protein level by immunocytochemistry and at the mRNA level by reverse transcription-polymerase chain reaction (RT-PCR). A high amount of AFP was also detected in the supernatant of cultured AME-1. The AME-1 cell line expressed c-Met both at the mRNA and protein levels. A semiquantitative RT-PCR method indicated that AME-1 had a higher amount of c-Met mRNA than well-known gastric cancer cell lines (MKN-28, MKN-45) with strong c-Met expression. Hepatocyte growth factor (HGF), a ligand for the c-Met receptor, was not detected in the mRNA or protein of AME-1. The AME-1 cell line showed a proliferative response to exogenous HGF treatment in a dose-dependent manner, but the activity of migration was not stimulated by exogenous HGF.
  
  
  CONCLUSIONS
  The AME-1 cell line may be a useful model for elucidating aggressive behavior, especially related to regulation of the c-Met/HGF system, in AFP-producing gastric cancers.
authors.affiliation: First Department of Surgery, Yamanashi Medical University, 1110 Shimokato, Tamaho, Nakakoma, Yamanashi 409-3898, Japan.
authors.forename: Hideki
authors.initials: H
authors.lastname: Amemiya
authors.forename: Koji
authors.initials: K
authors.lastname: Kono
authors.forename: Akihiro
authors.initials: A
authors.lastname: Takahashi
authors.forename: Shigeo
authors.initials: S
authors.lastname: Kamei
authors.forename: Hidemitsu
authors.initials: H
authors.lastname: Sugai
authors.forename: Fumiko
authors.initials: F
authors.lastname: Ichihara
authors.forename: Hideki
authors.initials: H
authors.lastname: Fujii
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Matsumoto
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology; D002460:Cell Line; D017228:Hepatocyte Growth Factor / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D019859:Proto-Oncogene Proteins c-met / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013274:Stomach Neoplasms / Q000378:metabolism* / Q000473:pathology; D000509:alpha-Fetoproteins / Q000378:metabolism*
chemical_list: D012333:RNA, Messenger; D000509:alpha-Fetoproteins; D017228:Hepatocyte Growth Factor; D019859:Proto-Oncogene Proteins c-met